NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

Let’s see. I was right in my opinion that the trial would reach statistical significance for survival.

You asserted the 232 vs 99 OS would be stat sig.,

Besides the fact that technically it could not be once PFS failed (that nasty alpha allocation that you fail to grasp), anybody with eyes open knows that comparison failed, and likely badly.

That the post hoc ECA analysis was stat sig is a joke. NWBO's trial was far more selective in enrolling healthy patients.